Prostaglandin analogs

Details for Australian Patent Application No. 2005270230 (hide)

Owner Allergan, Inc.

Inventors Old, David W.; Dinh, Danny T.

Agent Davies Collison Cave

Pub. Number AU-B-2005270230

PCT Pub. Number WO2006/014207

Priority 60/584,962 02.07.04 US; 60/600,165 09.08.04 US

Filing date 2 June 2005

Wipo publication date 9 February 2006

Acceptance publication date 31 May 2012

International Classifications

C07D 279/06 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

C07D 239/10 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 265/10 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Event Publications

25 January 2007 PCT application entered the National Phase

  PCT publication WO2006/014207 Priority application(s): WO2006/014207

31 May 2012 Application Accepted

  Published as AU-B-2005270230

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005270302-Lipid metabolic and signalling pathways in the epidermis

2005270229-Prostaglandin analogs